Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity

Nephrology Dialysis Transplantation

Volumn 20, Issue 7, 2005, Pages 1456-1462

  Holzmacher, Ryan ^a   Kendziorski, Christina ^b   Michael, Hofman R ^a   Jaffery, Jonathan ^a   Becker, Bryan ^a   Djamali, Arjang ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NONE   (United States)

Author keywords

Allograft; Cyclosporin; Kidney; Magnesium; Outcomes; Transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAGNESIUM; OKT 3; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DRUG POTENTIATION; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPOMAGNESEMIA; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; FOLLOW UP; HOSPITALIZATION; KIDNEY DISEASE; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MAGNESIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 26044476336     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh831     Document Type: Article

References (20)

1. Djamali A, Premasathian N, Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol 2003; 23: 306-316
2. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590
3. Djamali A, Kendziorski C, Brazy PC, Becker BN. Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int 2003; 64: 1800-1807
4. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-1100
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333
6. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940
7. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003; 23: 465-476
8. Mahawar KK. Cyclosporine withdrawal in stable renal transplant recipients. Transplantation 2003; 76: 1240-1241
9. Miura K, Nakatani T, Asai T et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation 2002; 73: 340-347
10. Barton CH, Vaziri ND, Mina-Araghi S, Crosby S, Seo MI. Effects of cyclosporine on magnesium metabolism in rats. J Lab Clin Med 1989; 114: 232-236
11. Wong NL, Dirks JH. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats. Clin Sci (Land) 1988; 75: 509-514
12. Mazzola BL, Vannini SD, Truttmann AC et al. Long-term calcineurin inhibition and magnesium balance after renal transplantation. Transplant Int 2003; 16: 76-81
13. Thakur V, Kumar R, Dhawan IK. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients. Ann Clin Biochem 2002; 39: 70-72
14. Vannini SD, Mazzola BL, Rodoni L et al. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine. Transplant Int 1999; 12: 244-249
15. Asai T, Nakatani T, Tamada S et al. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation. Transplantation 2003; 75: 1040-1044
16. Asai T, Nakatani T, Yamanaka S et al. Magnesium supplementation prevents experimental chronic cyclosporine A nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation 2002; 74: 784-791
17. Pere AK, Lindgren L, Tuomainen P et al. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney Int 2000; 58: 2462-2472
18. Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Part 4 - Definition and Classification of Stages of Chronic Kidney Disease. Am J Kidney Dis 2002; 39: S46-S75
19. Yu L, Alan SL. Renal magnesium handling. In: Brenner BM, Rector FC. Brenner & Rector's the Kidney, 7th edn. Saunders; 2004: 546-551
20. 2+ ions. Nephrol Dial Transplant 2003; 18: 2262-2268